Normal function · from ai-gene-review (P19544, commit 79fe13b38970) · AI-generated, not KB evidence

ai-gene-review has this gene at status IN_PROGRESS; the description is shown only once the review is complete. Read the draft upstream.

In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
46,XX testicular disorder of sex development causative de novo
mechanism: WT1 C-terminal regulatory alteration
subtype: WT1-related
scoped to subtype: WT1-related
46,XY partial gonadal dysgenesis causative germline
mechanism: WT1 sequence alteration
subtype: WT1-related PGD
Acute Myeloid Leukemia with CEBPA Somatic Mutations modifier somatic
scoped to subtype: CEBPA bZIP In-Frame-Indel AML
Aniridia causative
mechanism: WT1 Haploinsufficiency in the Contiguous 11p13 Deletion
subtype: WAGR
scoped to subtype: WAGR
Congenital Diaphragmatic Hernia causative
Denys-Drash Syndrome causative germline
Frasier Syndrome causative germline
Mixed Phenotype Acute Leukemia somatic driver somatic
mechanism: Immature T-Lineage Program with Retained Myeloid Potential
scoped to subtype: MPAL T/myeloid NOS
Pelvic Organ Prolapse susceptibility
WT1-Related Wilms Tumor Predisposition causative germlinesomatic loss of function
CLINGEN: definitive
mechanism: Biallelic WT1 Loss in Nephron Progenitors; Constitutional WT1 Haploinsufficiency in Gonadal and Glomerular Development; Germline WT1 Loss-of-Function; Somatic Paternal Uniparental Disomy of 11p
Meacham syndrome untyped
Causal heterozygous missense mutation
Wilms Tumor untyped
Tumor Suppressor Loss
mechanism: WT1 Inactivation
WAGR Syndrome no genetic record
mechanism: Somatic biallelic WT1 inactivation in renal precursor cells; WT1 haploinsufficiency and Wilms tumor predisposition
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
Wilms tumor 1 MONDO:0008679 AD Definitive
2020-07-30
Denys-Drash syndrome MONDO:0008682 AD Definitive
2021-07-27
Mechanism modules · computed from kb/

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.